-
Mar 9, 2026, 4:32 pm50 ptsTelehealth company Hims & Hers on Monday announced a "strategic shift" in its business model, partnering with pharmaceutical company Novo Nordisk to sell its blockbuster GLP-1 medication and stop selling the "copycat" compounded versions it has long advertised. In a press release, Hims & Hers said…
BUSTED: Fox & Friends Used Deceptive Footage After Trump Disrespects Fallen Soldiers Crooks and Liars 164
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.






